Money A2Z Web Search

Search results

1. Results From The WOW.Com Content Network

2. New immunotherapy shows promise for advanced colorectal ...

   www.aol.com/immunotherapy-shows-promise-advanced...

   A combination of two monoclonal antibodies was effective in 61% of people with the most common form of colorectal cancer, results from a new phase 1 trial indicate.

3. Colorectal cancer - Wikipedia

   en.wikipedia.org/wiki/Colorectal_cancer

   Colorectal cancer ( CRC ), also known as bowel cancer, colon cancer, or rectal cancer, is the development of cancer from the colon or rectum (parts of the large intestine ). [5] Signs and symptoms may include blood in the stool, a change in bowel movements, weight loss, abdominal pain and fatigue. [9] Most colorectal cancers are due to old age ...

4. US FDA approves Bristol Myers' colorectal cancer therapy

   www.aol.com/news/us-fda-approves-bristol-myers...

   (Reuters) -The U.S. Food and Drug Administration has approved Bristol Myers Squibb's combination therapy for treating colorectal cancer in patients with a specific gene mutation, the health ...

5. Immunotherapy Before Surgery Leads to Better Outcomes for ...

   www.aol.com/lifestyle/immunotherapy-surgery...

   In a study involving over 100 patients, a dual-drug immunotherapy treatment shows impressive results in treating a specific form of colorectal cancer.

6. FOLFOX - Wikipedia

   en.wikipedia.org/wiki/FOLFOX

   FOLFOX is a chemotherapy regimen for treatment of colorectal cancer, made up of the drugs folinic acid ( leucovorin, FOL ), fluorouracil (5-FU, F ), and oxaliplatin (Eloxatin, OX ). [1]

7. FOLFOXIRI - Wikipedia

   en.wikipedia.org/wiki/FOLFOXIRI

   "FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study".